Shanghai Fosun Pharmaceutical takes stake in Impax Labs By: MarketMinute.com Stock News August 31, 2017 at 17:22 PM EDT Shanghai Fosun Pharmaceutical acquired a 5.19% stake in Impax Laboratories Inc. (Nasdaq: IPXL). The stock price leaped $3.70 to close at $21.65.